News
Johannesberg: Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its ...
Bizcommunity on MSN6d
Danish weight-loss drug Wegovy debuts in South Africa, challenging Eli Lilly
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa, marking its debut in Africa and ...
Updated on: May 12, 2025 / 12:39 PM EDT / CBS News ...
Celeste Ntuli opened up on her battle with obesity. The star's comments comes as Mzansi is discussing the new looks of celebs ...
Wegovy was the first to market from a newer generation of medicines known as GLP-1 agonists, originally developed for diabetes, that provide a new way to address record obesity rates.
Key Takeaways Wegovy is considered a safe and effective treatment for long-term weight loss. Possible problems with long-term use include pancreatitis, gallbladder disease, and kidney damage.
Wegovy’s starting dosage is a 0.25-milligram (mg) injection once per week. You’ll typically increase your dose every 4 weeks, up to 1.7 mg per week or 2.4 mg per week. Your doctor may adjust ...
U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...
While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured ...
Keep reading to learn about the common, mild, and serious side effects that Wegovy can cause. For a general overview of the drug, including details about its uses, see this Wegovy overview.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback